Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Processa Pharmaceuticals, Inc. (PCSA) Message Board

Risks Associated with Prolonged Sitting Can Be Cou

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 40
(Total Views: 204)
Posted On: 12/04/2020 2:26:35 AM
Avatar
Posted By: NetworkNewsWire
Risks Associated with Prolonged Sitting Can Be Counteracted by Engaging in Physical Activity

Recent guidelines introduced by the World Health Organization (WHO) on sedentary behavior and physical activity show that indulging in weekly physical activities can neutralize the health harms linked to prolonged sitting. These guidelines were reported in as special issue of “British Journal of Sports Medicine.” The article notes that all physical activity is good for a person’s health in the long term.

This is the first time that such recommendations have been made, which indicates that there’s growing evidence that connects a sedentary lifestyle to grave ill health and an increased risk of early death. Data that was released last week in the same issue demonstrated that grown-ups who spend most of their time seated can balance out these risks by increasing the physical activity they indulge in every day.

This research, which involved more than 44,000 individuals from four nations, required the participants to wear activity trackers. The research revealed that if the majority of the time in the day of a person was spent seated, this was associated with a significantly increased risk of death, especially for individuals who were not physically active.

Do not despair, however. The research findings show that 30 to 40 minutes of physical activity, whether vigorous or moderate, considerably reduced this risk. This brought the risk levels down to those linked to low sedentary time. This confirms the guidelines that were cited in the 2020 WHO Universal Guidelines on Sedentary Behavior and Physical Activity.

The guidelines add that while there may not be enough evidence to help in suggesting specified thresholds for a stationary lifestyle, everybody should try to engage in physical activity. This will help reduce their everyday sedentary time. There’s no prescribed physical activity to partake in, as all physical activities count. This may include participating in a team sport, riding a bike, going for a jog, doing your household chores, gardening, walking or even choosing to take the stairs instead of the elevator.

WHO guidelines advocate for spending no less than 75 minutes every week partaking in activities of vigorous intensity or between two to five hours taking part in activities of moderate intensity. It should be noted that it is significantly better for your health to engage in any physical activity as opposed to none at all.

The guidelines explain that any individual who is unable to meet the aforementioned recommendations should start small and slowly grow the duration, intensity and frequency of their physical activity at a steady pace. Additionally, the guidelines highlight the importance of partaking in muscle strengthening and aerobic activities.

Many biomedical companies are engaged in finding solutions to the health-care needs of communities. One such company is Processa Pharmaceuticals Inc. (NASDAQ: PCSA). Among other interests, Processa acquires drugs for which clinical evidence of effectiveness exists, and then the company completes the regulatory requirements needed to gain approval for the drug.

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer



(0)
(0)




Processa Pharmaceuticals, Inc. (PCSA) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us